Dr.pharmacist
Imodium AD

Imodium AD

loperamide

OTC DrugImodium AD
Reviewed by Younghun Cho

Pharmacist's Verdict

Imodium AD is a highly effective over-the-counter medication for quickly relieving symptoms of sudden, non-infectious diarrhea. It's a reliable choice for most adults and children over 6 to reduce stool frequency and improve consistency.

Ingredient Analysis

Loperamide Hydrochloride

Pros & Cons

Pros

  • Works quickly to reduce the frequency and watery nature of stools, providing fast relief from diarrhea.
  • Easily available in most drugstores and supermarkets without a prescription, making it convenient.
  • Has been used for many years and is generally safe when taken exactly as directed on the label.
  • Comes in various easy-to-use forms like caplets and chewable tablets.

Cons

  • Treats the symptom (diarrhea) but not the cause; if your diarrhea is due to a serious infection, it might keep the infection in your body longer.
  • Should not be used for diarrhea with fever, blood in the stool, or if you suspect a serious bacterial infection.
  • Can cause constipation if you take too much or use it for too long.
  • There's a risk of serious heart problems if misused or taken in very high doses, which is why sticking to the recommended dose is vital.
  • Not for children under 6 without a doctor's advice, and avoid if you have certain bowel conditions like a flare-up of ulcerative colitis.

References

  1. 1.
    FDA Drug Label — anti diarrheal

    FDA DailyMed: anti diarrheal · FDA

  2. 2.
    Clinical management of high-output stoma: a systematic literature review and meta-analysis.

    Lederhuber H, Massey LH, Kantola VE, et al., Techniques in coloproctology, 2023 · PubMed

  3. 3.
    Constipation and Fecal Incontinence in the Elderly.

    Deb B, Prichard DO, Bharucha AE, Current gastroenterology reports, 2020 · PubMed

  4. 4.
    Low anterior resection syndrome.

    Ryoo SB, Annals of gastroenterological surgery, 2023 · PubMed

  5. 5.
  6. 6.
    Guidance on the management of diarrhoea during cancer chemotherapy.

    Andreyev J, Ross P, Donnellan C, et al., The Lancet. Oncology, 2014 · PubMed